TIFFANY MORGAN: Open Payments
NPI 1083913305 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 60 payments from 14 companies in 2025. Trend: 2023 $566 · 2024 $723 · 2025 $1,151
Food & beverage: $1,120Education: $31
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $275 |
| ABBVIE INC. | 14 | $199 |
| Intercept Pharmaceuticals, Inc. | 5 | $114 |
| GENZYME CORPORATION | 4 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Ardelyx, Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| PFIZER INC. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Aimmune Therapeutics, Inc. | 3 | $46 |
Products named: TREMFYA, DUPIXENT, OCALIVA, RINVOQ, IBSRELA, XIFAXAN, EOHILIA, CREON.
Industry payments across SC — which companies pay providers there.
